EnsiliTech

Stephen is a co-inventor of the ensilication method along with Asel, and as a multidisciplinary researcher and Chemistry Lecturer at the University of Bath, provides EnsiliTech scientific advice, with a particular focus on intellectual property.

Following/during her PhD at Cambridge University, Asel began developing ensilication technology to stabilise bio-pharmaceuticals in 2012, which led to the co-founding of EnsiliTech ten years later. Asel leads the company as CEO while also supervising PhD students as an Associate Professor in Chemistry at the University of Bath, as well as being an Enterprise Fellow at the Royal Academy of Engineering and a UNICEF Ambassador for its ‘Girls in Science’ programme.

Aswin became involved in the development of ensilication during his PhD at the University of Bath, and continued to work on it as a postdoc up until EnsiliTech was founded. His background in physical chemistry, biochemistry and microbiology enables him to utilise a multidisciplinary approach to vaccine formulation and stability.

Matt’s involvement in ensilication technology began during his PhD at the University of Bath, studying under Asel Sartbaeva. Since co-founding EnsiliTech, Matt’s focus at the company has been market research and validation, closing its pre-seed investment round, administering Innovate UK grants and ensuring the smooth running of day-to-day operations.